Spotlight on Alzheimer’s Disease
On December 10, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Alzheimer’s disease. They learned about living with Alzheimer’s disease, current treatments for Alzheimer’s, and prospects for bringing stem cell-based Alzheimer’s therapies to clinical trial.
- Welcoming remarks: Robert Klein, J.D., Chair of the Governing Board and Leeza Gibbons, member of the Governing Board
- Dick Mora, patient with Alzheimer’s disease
- William Rodman Shankle, M.D., Founder and Medical Director, Shankle Clinic for Alzheimer’s Disease and Related Disorders
- Frank LaFerla, Ph.D., Director, Institute for Brain Aging and Dementia
